Teicoplanin vs vancomycin: Clinical efficacy ‐ cure or improvement at
Teicoplanin showed no clear difference in clinical cure or improvement compared with vancomycin (moderate certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Teicoplanin vs vancomycin Clinical cure or improvement · patients with proven or suspected infection Teicoplanin showed no clear difference in clinical cure or improvement compared with vancomycin (moderate certainty). Teicoplanin versus vancomycin for proven or suspected infection (2010) · Cochrane Headline outcomes only | RR 1.03 [0.98, 1.08] | 20 studies · 1703 participants | Moderate |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Teicoplanin versus vancomycin for proven or suspected infection 2010 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.